These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, Park JS, Salonen JT. Circulation; 1995 Oct 01; 92(7):1758-64. PubMed ID: 7671358 [Abstract] [Full Text] [Related]
6. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. MacMahon S, Sharpe N, Gamble G, Hart H, Scott J, Simes J, White H. Circulation; 1998 May 12; 97(18):1784-90. PubMed ID: 9603532 [Abstract] [Full Text] [Related]
7. Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study. Probstfield JL, Margitic SE, Byington RP, Espeland MA, Furberg CD. Am J Cardiol; 1995 Sep 28; 76(9):47C-53C. PubMed ID: 7572686 [Abstract] [Full Text] [Related]
8. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Furberg CD, Adams HP, Applegate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA. Circulation; 1994 Oct 28; 90(4):1679-87. PubMed ID: 7734010 [Abstract] [Full Text] [Related]
9. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation. Pitt B, Mancini GB, Ellis SG, Rosman HS, Park JS, McGovern ME. J Am Coll Cardiol; 1995 Nov 01; 26(5):1133-9. PubMed ID: 7594023 [Abstract] [Full Text] [Related]
11. Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary Arteries. Furberg CD, Pitt B, Byington RP, Park JS, McGovern ME. Am J Cardiol; 1995 Sep 28; 76(9):60C-63C. PubMed ID: 7572689 [Abstract] [Full Text] [Related]
15. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN. Circulation; 2002 Oct 15; 106(16):2055-60. PubMed ID: 12379573 [Abstract] [Full Text] [Related]
19. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study. de Groot E, Jukema JW, van Boven AJ, Reiber JH, Zwinderman AH, Lie KI, Ackerstaff RA, Bruschke AV. Am J Cardiol; 1995 Sep 28; 76(9):40C-46C. PubMed ID: 7572685 [Abstract] [Full Text] [Related]